Suxia Han
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research
Papers in
-
- Radiation Therapy and Dosimetry 5
- Ferroptosis and cancer prognosis 4
- Prostate Cancer Treatment and Research 3
- Co-authors
- Qing Zhu (20 shared papers)Jinlu Ma (20 shared papers)Mengjiao Cai (12 shared papers)Chenchen He (12 shared papers)Yiping Dong (12 shared papers)Congya Zhou (7 shared papers)Xia Ying (6 shared papers)Xinyue Tan (9 shared papers)
- Journals
- Oncotarget (5 papers)Journal of Immunology Research (4 papers)Frontiers in Oncology (3 papers)Small (3 papers)Oncology Reports (3 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Suxia Han
69 papers receiving 1.8k citations
Suxia Han's Hit Papers
Peers
Comparison fields: 5 of 90
- Cancer Research 273
- Oncology 276
- Hepatology 79
- Pulmonary and Respiratory Medicine 266
- Cell Biology 114
Countries citing papers authored by Suxia Han
This map shows the geographic impact of Suxia Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suxia Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suxia Han more than expected).
Fields of papers citing papers by Suxia Han
This network shows the impact of papers produced by Suxia Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suxia Han. The network helps show where Suxia Han may publish in the future.
Co-authors
The 25 scholars most cited alongside Suxia Han, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 117 | |
| 2 | 2015 | 101 | |
| 3 | 2012 | 94 | |
| 4 | 2022 | 90 | |
| 5 | 2010 | 85 | |
| 6 | 2015 | 78 | |
| 7 | 2015 | 67 | |
| 8 | 2018 | 56 | |
| 9 | 2023 | 46 | |
| 10 | 2013 | 44 | |
| 11 | 2014 | 42 | |
| 12 | 2022 | 42 | |
| 13 | 2012 | 38 | |
| 14 | 2018 | 35 | |
| 15 | 2019 | 35 | |
| 16 | 2014 | 34 | |
| 17 | A ROS-mediated oxidation-O-GlcNAcylation cascade governs ferroptosis Hit paper breakdown → | 2025 | 32 |
| 18 | 2019 | 30 | |
| 19 | 2021 | 29 | |
| 20 | 2013 | 28 |
About Suxia Han
Suxia Han is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Oncology, Molecular Biology and Hepatology, having authored 74 papers that have together received 1.8k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Ubiquitin and proteasome pathways (5 papers), Radiation Therapy and Dosimetry (5 papers), DNA Repair Mechanisms (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Ferroptosis and cancer prognosis (4 papers) and Prostate Cancer Treatment and Research (3 papers). The work is most often cited by research in Cancer Research (273 citations), Oncology (276 citations), Hepatology (79 citations), Pulmonary and Respiratory Medicine (266 citations) and Cell Biology (114 citations). Suxia Han has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Qing Zhu, Jinlu Ma, Mengjiao Cai, Chenchen He, Yiping Dong, Congya Zhou, Xia Ying, Xinyue Tan, Peijun Liu and Lijuan Wang. Their work appears in journals such as Oncotarget, Journal of Immunology Research, Frontiers in Oncology, Small and Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.